126 related articles for article (PubMed ID: 23534747)
21. Locally recurrent parathyroid neoplasms as a cause for recurrent and persistent primary hyperparathyroidism.
Fraker DL; Travis WD; Merendino JJ; Zimering MB; Streeten EA; Weinstein LS; Marx SJ; Spiegel AM; Aurbach GD; Doppman JL
Ann Surg; 1991 Jan; 213(1):58-65. PubMed ID: 1985539
[TBL] [Abstract][Full Text] [Related]
22. A patient with persistent primary hyperparathyroidism due to a second ectopic adenoma.
Hamdy NA
Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):311-5. PubMed ID: 17315039
[TBL] [Abstract][Full Text] [Related]
23. Metachronous primary hyperparathyroidism due to a parathyroid adenoma and a subsequent carcinoma: report of a case.
Ito Y; Iwase H; Tanaka H; Yuasa H; Kureyama Y; Yamashita H; Toyama T; Kimura M; Kobayashi S
Surg Today; 2001; 31(10):895-8. PubMed ID: 11759885
[TBL] [Abstract][Full Text] [Related]
24. Persistent hypocalcemia with elevated parathyroid hormone levels after long-term primary hyperparathyroidism: report of a case.
Heuser M; Markus P; Obenauer S; Hüfner M; Becker H
Surg Today; 2000; 30(11):1008-11. PubMed ID: 11110396
[TBL] [Abstract][Full Text] [Related]
25. Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?
Randhawa PS; Mace AD; Nouraei SA; Stearns MP
Clin Otolaryngol; 2007 Jun; 32(3):179-84. PubMed ID: 17550505
[TBL] [Abstract][Full Text] [Related]
26. Undescended parathyroid adenoma.
Kanack MD; Maawy AA; Oh DK; Bouvet M
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25737222
[TBL] [Abstract][Full Text] [Related]
27. [Diagnosis and treatment of osteopathic parathyroid adenoma].
Xu HZ; Li Y; Zhao YF
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Nov; 17(6):446-9. PubMed ID: 14663938
[TBL] [Abstract][Full Text] [Related]
28. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
29. Primary hyperparathyroidism from parathyroid microadenoma.
Agrawal R; Agarwal S; Mishra A; Agarwal G; Agarwal A; Verma AK; Mishra SK; Chand G
J Am Coll Surg; 2010 Sep; 211(3):436-7; author reply 437-8. PubMed ID: 20800204
[No Abstract] [Full Text] [Related]
30. [Ultrasonic evaluation of primary hyperparathyroidism].
Borrè A; Gremo L; Isolato G; Gasparri G; Isaia GC
Radiol Med; 1988 Mar; 75(3):200-3. PubMed ID: 3282275
[TBL] [Abstract][Full Text] [Related]
31. Preoperative identification of tumor of the parathyroid by ultrasonotomography.
Arima M; Yokoi H; Sonoda T
Surg Gynecol Obstet; 1975 Aug; 141(2):242-4. PubMed ID: 1154235
[TBL] [Abstract][Full Text] [Related]
32. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
33. [Parathyroid disease: The full spectrum, from adenoma to carcinoma. Report of 3 cases].
Stoopen-Margain E; Valanci-Aroesty S; Castañeda-Martínez L; Baquera-Heredia J; Sainz-Hernández JC
Cir Cir; 2017; 85(6):549-551. PubMed ID: 27855990
[TBL] [Abstract][Full Text] [Related]
34. Large retrosternal parathyroid carcinoma with primary hyperparathyroidism.
Tan GC; Shiran MS; Swaminathan M; Phang KS; Rohaizak M
Asian J Surg; 2007 Oct; 30(4):286-9. PubMed ID: 17962134
[TBL] [Abstract][Full Text] [Related]
35. [A symptomatic parathyroid adenoma. Value of parathyroid hormone determination through selective catheterization of the thyroid veins].
Ribot C; Dutau G; Manelfe C; Bouissou H; Rochiccioli P
Arch Fr Pediatr; 1977 Feb; 34(2):171-8. PubMed ID: 194545
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid carcinoma; a cause of recurrent primary hyperparathyroidism a few years after removal of a parathyroid adenoma.
Delikaris P; Poulsen J; Løvgreen NA; Skjoldborg H
Acta Chir Scand; 1981; 147(5):335-8. PubMed ID: 7324759
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness of Intraoperative Parathyroid Monitoring (ioPTH) in predicting a multiglandular or malignant parathyroid disease.
Dobrinja C; Santandrea G; Giacca M; Stenner E; Ruscio M; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S26-S33. PubMed ID: 28506410
[TBL] [Abstract][Full Text] [Related]
38. [Surgical therapy concept in primary hyperparathyroidism].
Rusterholz D; Müller W
Schweiz Med Wochenschr Suppl; 2000; 116():62S-65S. PubMed ID: 10780075
[TBL] [Abstract][Full Text] [Related]
39. Parafibromin immunohistochemical staining to differentiate parathyroid carcinoma from parathyroid adenoma.
Kim HK; Oh YL; Kim SH; Lee DY; Kang HC; Lee JI; Jang HW; Hur KY; Kim JH; Min YK; Chung JH; Kim SW
Head Neck; 2012 Feb; 34(2):201-6. PubMed ID: 21717519
[TBL] [Abstract][Full Text] [Related]
40. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.
Robert JH; Trombetti A; Garcia A; Pache JC; Herrmann F; Spiliopoulos A; Rizzoli R
Ann Surg Oncol; 2005 Jul; 12(7):526-32. PubMed ID: 15889214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
